Ribosome structure determination from Apicomplexan parasites
顶复门寄生虫的核糖体结构测定
基本信息
- 批准号:10726704
- 负责人:
- 金额:$ 25.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-24 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffinityAffinity ChromatographyAnimal DiseasesAnimalsAnti-Bacterial AgentsAntibioticsAntiparasitic AgentsApicomplexaAreaBabesiaBabesiosisBindingBiologyClinicalComplexCryoelectron MicroscopyCytoplasmCytoplasmic StructuresCytosolDevelopmentDiseaseDrug resistanceElementsErythrocytesEventFeverFoundationsGene ExpressionGene Expression RegulationGeographic DistributionGeographyGoalsGrowthHemagglutininHumanImmune systemImmunocompromised HostIndividualInfectionInorganic Phosphate TransporterLaboratoriesLifeLife Cycle StagesMalariaMembraneMethodsMitochondriaMolecularMolecular BiologyMolecular StructureNMR SpectroscopyNamesOrganellesOrganismParasitesPathway interactionsPharmaceutical PreparationsPlasmodiumPlasmodium falciparumPreparationPropertyProtein BiochemistryProtein BiosynthesisProtocols documentationPublic HealthResearch ProposalsResolutionRibosomal ProteinsRibosomal RNARibosomesStructureSymptomsTherapeutic InterventionThickTick-Borne DiseasesToxoplasmaToxoplasmosisTranslationsVaccinesWorkX-Ray Crystallographyantibiotic designclimate changedesignexperienceexperimental studyforesthuman diseaseimprovednovelnovel therapeuticsparticleposttranscriptionalrational designstructural biologysuburbtargeted agenttargeted treatmenttick-borne
项目摘要
PROJECT SUMMARY/ABSTRACT
The Apicomplexa phylum contains many parasites that infect and cause disease in humans and animals,
including the agents that cause malaria, toxoplasmosis, and babesiosis. Babesia is a tick-borne intracellular
parasite that causes severe to fatal diseases, with broadening geographic distribution because of climate change
and increasing suburban developments in forested areas. There is no vaccine against human babesiosis, and
the current therapies have limited efficacy. Considering the complex life cycle of Babesia species, their survival
depends on the precise control of their gene expression, which is mostly regulated post-transcriptionally (e.g.,
during protein synthesis). Babesia species have a unique, non-photosynthetic organelle named apicoplast,
derived from a secondary endosymbiotic event. In addition to having ribosomes in its cytoplasm and
mitochondria, the apicoplast contains its own ribosomes. Little is known about the structure of these ribosomes,
although they are thought to be highly simplified, with prokaryotic-like components. They are inhibited by
antibacterial drugs that have some limited antiparasitic activity. The absence of a molecular structure of any
apicoplast ribosomes limits the rational design of antibiotics with improved antiparasitic properties. In the first
aim of this research proposal, we will establish a Babesia divergens strain expressing an hemagglutinin (HA)-
tagged triose phosphate transporter on the outer membrane of the apicoplast. This strategy will allow the affinity
purification of a high-quality organelle preparation, followed by the purification of apicoplast ribosomes. In the
second aim, we will define the components of apicoplast ribosomes and determine their structure using cryo-
electron microscopy (cryo-EM). Our goal is thus to elucidate the fundamental molecular machinery that
apicomplexan parasites use to synthesize proteins in the highly specialized apicoplast organelle. Our work will
lay the foundation for studies that interrogate these parasites' gene regulation mechanisms and help inspire the
design of better antiparasitic agents.
项目总结/摘要
顶复门含有许多寄生虫,它们感染人类和动物并引起疾病,
包括导致疟疾、弓形虫病和巴贝虫病的病原体。巴贝虫是一种蜱传的细胞内
一种导致严重至致命疾病的寄生虫,由于气候变化,其地理分布范围扩大
以及在森林地区增加郊区开发。目前还没有针对人类巴贝斯虫病的疫苗,
目前的疗法具有有限的功效。考虑到巴贝虫物种复杂的生命周期,
依赖于对它们基因表达的精确控制,而基因表达主要是在转录后调节的(例如,
蛋白质合成)。Bababelles物种有一个独特的,非光合作用的细胞器称为顶质体,
源自次级内共生事件。除了在细胞质中有核糖体,
线粒体、顶质体含有自己的核糖体。人们对这些核糖体的结构知之甚少,
尽管它们被认为是高度简化的,具有类似原核生物的成分。它们被抑制,
抗寄生虫活性有限的抗菌药物。缺乏任何分子结构
顶质体核糖体限制了具有改进的抗寄生虫特性的抗生素的合理设计。上
为了实现本研究的目的,我们将建立表达血凝素(HA)的分歧巴氏杆菌菌株,
在顶质体的外膜上标记的磷酸丙糖转运蛋白。这种策略将使亲和力
纯化高质量的细胞器制剂,然后纯化顶质体核糖体。在
第二个目标,我们将确定顶质体核糖体的组成部分,并确定其结构,
电子显微镜(cryo-EM)。因此,我们的目标是阐明
顶复体寄生虫用于在高度特化的顶质体细胞器中合成蛋白质。我们的工作将
为研究这些寄生虫的基因调控机制奠定了基础,
设计更好的抗寄生虫药。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa Leger-Abraham其他文献
Melissa Leger-Abraham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa Leger-Abraham', 18)}}的其他基金
Structural Basis for Translation Initiation in Leishmania Major
大利什曼原虫翻译起始的结构基础
- 批准号:
10225842 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
Structural Basis for Translation Initiation in Leishmania Major
大利什曼原虫翻译起始的结构基础
- 批准号:
10373100 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 25.43万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 25.43万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 25.43万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 25.43万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 25.43万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 25.43万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 25.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 25.43万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




